In a highly unusual move, a small biotech has disclosed a rejection letter from the FDA in hopes of rallying support for ...

Kennedy would be less hazardous if he decided to do cardiac surgery. Then he would kill people only one at a time,” writes ...

High publishing costs and a crumbling peer review infrastructure are symptoms of deeper structural issues in research.

The top executives running the health care industry’s blue-chip companies amassed generational wealth in 2024, even as many ...

A draft of RFK Jr.'s much-awaited strategy for a healthier America softens rhetoric on agricultural chemicals and stresses ...

Last November, in the days following Donald Trump’s election, leaders at the National Institutes of Health began discussing ...

Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators to treat an increasingly common liver disease, MASH.

A new study suggests that, after having a specialized AI tool taken away, clinicians were less proficient at colonoscopies.

In RFK Jr.’s America, it will never be safe to practice public health or medicine," write an epidemiologist and a former CDC ...

With U.S. funding for science at risk, a longtime advocate sees ‘light at the end of the tunnel’ in Washington.

Eli Lilly said it would raise drug prices in Europe to "make them lower" in U.S., though the actual impact on most patients ...

Eli Lilly plans to increase prices of medicines in Europe and other developed markets “in order to make them lower” in the ...